Versant Capital Management
OLMA icon

Versant Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Versant Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.7K Sell
1,122
-76
-6% -$828 ﹤0.01% 2278
2026
Q2 		$15K Sell
1,198
-181
-13% -$2.42K ﹤0.01% 2073
2026
Q1 		$20.6K Buy
1,379
+201
+17% +$4.48K ﹤0.01% 1807
2025
Q4 		$29.4K Sell
1,178
-245
-17% -$4.36K ﹤0.01% 1395
2025
Q3 		$13.9K Buy
1,423
+488
+52% +$2.93K ﹤0.01% 1775
2025
Q2 		$3.98K Sell
935
-668
-42% -$2.98K ﹤0.01% 2237
2025
Q1 		$6.03K Buy
1,603
+960
+149% +$4.83K ﹤0.01% 1962
2024
Q4 		$3.75K Buy
+643
New +$6.42K ﹤0.01% 1894

Other funds holding OLMA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Versant Capital Management's OLMA Position: Q3 2026 in Review

Versant Capital Management reduced its Olema Pharmaceuticals (OLMA) stake by 6.3% in Q3 2026, selling an estimated $828 and leaving 1,122 shares worth $9.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Versant Capital Management first reported a position in OLMA in Q4 2024 and has held it in 8 quarters since. The position peaked at $29.4K in Q4 2025. 58 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Versant Capital Management held 1,122 shares of Olema Pharmaceuticals worth $9.7K as of Q3 2026.
  • Versant Capital Management sold 76 Olema Pharmaceuticals shares in Q3 2026, an estimated $828.
  • Olema Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2278 holding.
  • Versant Capital Management first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Versant Capital Management's Olema Pharmaceuticals position peaked at $29.4K in Q4 2025.
  • 58 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.